27 Dec, 09:39 - Indian

SENSEX 78720.22 (0.32)

Nifty 50 23831.349609375 (0.34)

Nifty Bank 51375.30078125 (0.40)

Nifty IT 43623.1015625 (-0.09)

Nifty Midcap 100 57188.6484375 (0.11)

Nifty Next 50 69240.046875 (0.11)

Nifty Pharma 22852.25 (0.62)

Nifty Smallcap 100 18762 (0.18)

27 Dec, 09:39 - Global

NIKKEI 225 40235.62 (1.69)

HANG SENG 20121.8 (0.12)

S&P 6096.5 (-0.18)

Cancel

BSE Code : 532296 | NSE Symbol : GLENMARK | ISIN : INE935A01035 | Industry : Pharmaceuticals |

(16-Dec-24 09:41) Glenmark Pharma arm launches seizure drug in US
(16-Dec-24 09:06) Glenmark Pharmaceuticals Inc. USA launches Lacosamide Oral Solution
(03-Dec-24 13:06) Glenmark Pharmaceuticals Ltd up for third straight session
(27-Nov-24 09:59) Glenmark Pharma arm launches Travoprost Ophthalmic Solution in U.S market
(27-Nov-24 09:12) Glenmark Pharma launches Travoprost Ophthalmic Solution USP
(18-Nov-24 13:35) Glenmark Pharmaceuticals Ltd eases for fifth straight session
(15-Nov-24 14:40) Glenmark Pharma reports turnaround Q2 results
(15-Nov-24 09:56) Glenmark Pharmaceuticals reports consolidated net profit of Rs 354.21 crore in the September 2024 quarter
(15-Nov-24 07:42) Glenmark Pharmaceuticals standalone net profit rises 96.81% in the September 2024 quarter
(06-Nov-24 13:05) Glenmark Pharmaceuticals Ltd gains for third straight session

1 2 3 4 5 6 7 8 9 10

Glenmark Pharmaceuticals Ltd